Suppr超能文献

使用钠氢交换抑制剂HOE 694延长低温缺血时间后心脏功能得到改善。

Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694.

作者信息

Myers M L, Karmazyn M

机构信息

Department of Cardiovascular Surgery, University of Western Ontario, London, Canada.

出版信息

Ann Thorac Surg. 1996 May;61(5):1400-6. doi: 10.1016/0003-4975(96)00088-4.

Abstract

BACKGROUND

Na+/H+ exchange represents an important mechanism for pH regulation in the cardiac cell that, however, may paradoxically mediate tissue damage in the reperfused myocardium. We investigated whether inhibition of the exchanger can protect the heart against damage after prolonged hypothermic storage with the use of the selective inhibitor 3-methylsulfonyl-4-piperidinobenzoyl-guanidine methanesulfonate (HOE 694).

METHODS

After equilibration, isolated rabbit hearts were arrested with a 3 minute infusion of modified St. Thomas' cardioplegic solution and subsequently maintained in ischemic arrest at 4 degrees C for 12 hours before reperfusion at 37 degrees C for 60 minutes. Left ventricular function and creatine kinase release were measured at intervals throughout reperfusion. High-energy phosphate and adenine nucleotide content were determined in hearts before cardioplegia, at the end of the 12-hour storage period, and at the end of reperfusion. HOE 694 (1 mumol/L) was administered either with cardioplegia and throughout reperfusion (study 1) or selectively with either cardioplegia or reperfusion only (study 2).

RESULTS

In study 1, systolic function in untreated hearts recovered to less than 40% of preischemic values and was associated with a greater than 1,000% percent sustained elevation in left ventricular end-diastolic pressure. In contrast, systolic recovery in HOE 694-treated hearts was significantly accelerated and improved to approximately 80%, whereas left ventricular end-diastolic pressure increased to only 300% of baseline. Significant protection also occurred in those hearts in which HOE 694 was administered only at reperfusion while the drug was less effective if given only during cardioplegia. Creatine kinase release was not significantly affected except in study 2, where it was significantly lower after 60 minutes of reperfusion in hearts where HOE 694 was added at the time of reperfusion. Tissue metabolite content was not affected by drug treatment.

CONCLUSIONS

This study shows a marked protective effect of the Na+/H+ exchange inhibitor HOE 694 in rabbit hearts subjected to 12 hours of hypothermic ischemia and strongly suggests that antiport inhibitors could play an effective role in myocardial preservation.

摘要

背景

钠氢交换是心脏细胞中调节pH值的重要机制,但在再灌注心肌中,它可能反常地介导组织损伤。我们研究了使用选择性抑制剂3 - 甲基磺酰基 - 4 - 哌啶基苯甲酰胍甲磺酸盐(HOE 694)抑制该交换体是否能保护心脏免受长时间低温保存后的损伤。

方法

平衡后,用改良的圣托马斯心脏停搏液灌注3分钟使离体兔心停搏,随后在4℃缺血停搏12小时,然后在37℃再灌注60分钟。在再灌注过程中间隔测量左心室功能和肌酸激酶释放。在心脏停搏前、12小时保存期结束时和再灌注结束时测定高能磷酸和腺嘌呤核苷酸含量。HOE 694(1μmol/L)在心脏停搏时及整个再灌注过程中给药(研究1),或仅在心脏停搏或再灌注时选择性给药(研究2)。

结果

在研究1中,未治疗心脏的收缩功能恢复至缺血前值的不到40%,且左心室舒张末期压力持续升高超过1000%。相比之下,HOE 694治疗心脏的收缩功能恢复明显加速,改善至约80%,而左心室舒张末期压力仅升至基线的300%。在仅在再灌注时给予HOE 694的心脏中也出现了显著的保护作用,而仅在心脏停搏时给药则效果较差。肌酸激酶释放除在研究2中显著受影响外,其他情况下无明显变化,在研究2中,再灌注60分钟后,再灌注时添加HOE 694的心脏中肌酸激酶释放明显较低。组织代谢物含量不受药物治疗影响。

结论

本研究表明钠氢交换抑制剂HOE 694对经历12小时低温缺血的兔心有显著保护作用,并强烈提示反向转运抑制剂在心肌保存中可发挥有效作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验